SARCLISA
Google image searchProduct monograph
Active ingredient
isatuximab, 100 MG/5 ML
DIN: 02498235
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS
Description: SINGLE-USE VIALS. FOR I.V. INFUSION
Schedule: Prescription / Schedule D
Company: SANOFI-AVENTIS CANADA INC
Date: 03-JUL-2020
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01F — MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES (ATC, ATC/DDD)
- L01FC — CD38 (Clusters of Differentiation 38) inhibitors (ATC, ATC/DDD)
- L01FC02 — ISATUXIMAB (ATC/DDD)
External Links for Sarclisa
Search on Google
Sanofi-Aventis Canada Inc
Go to Sanofi-Aventis website to see drug product details. Sometimes you can find sarclisa photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.